Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BRILINTA
- Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profile
- EVALUATION OF LOW DOSE COLCHICINE AND TICAGRELOR IN PREVENTION OF ISCHEMIC STROKE IN PATIENTS WITH STROKE DUE TO ATHEROSCLEROSIS
- Dual Antiplatelet Therapy in Patients With Clopidogrel Resistance Following Off-Pump Coronary Artery Bypass
- Differential EFfects of Dual antIplatelet and Dual aNtithrombotic thErapy on Hemostasis in Chronic Coronary Syndrome Patients
- A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy Participants
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
- Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting Condition
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects
- Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus
- Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI
- Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.
- Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
- Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
- Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS
- Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND
- Chewed Versus Integral Pill of Ticagrelor
- Chronic Kidney Disease (CKD) Platelet Study
- SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance to Examine the Safety of Cessation of Dual Anti-Platelet Therapy in High Bleeding Risk Patients at One Month
- Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study
- Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI
- Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI
- CES1 Crossover Trial of Clopidogrel and Ticagrelor
- Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD
- A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered
- Ticagrelor Versus High-dose Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After PCI
- Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor
- A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response
- Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
- Post-operative Treatment of Diabetic Peripheral Arterial Disease Guided by Platelet Reactivity Unit
- Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention
- The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation
- Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
- COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS
- Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor
- Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease
- Use of Ticagrelor in Korean ACS Patients: The BRILIANT KOREA Registry
- Ticagrelor Therapy for RefrACTORy Migraine Study
- Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel
- Ticagrelor vs. Prasugrel Effects on Infarct Size
- Platelet Reactivity in Acute Non-disabling Cerebrovascular Events
- Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting
- Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)
- Brilinta Taiwan Post Approval Safety Study
- Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine
- Genotype and Platelet Reactivity in Patients on Hemodialysis
- Reversal of the Anti-platelet Effects of Ticagrelor
- Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis
- Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
- A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
- Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery
- Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease
- Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina
- Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
- Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI
- Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia
- Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
- Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy
- Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI
- Reversing Ticagrelor's Effects With Fresh Platelets
- Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel
- Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function
- Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients
- DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury
- Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study
- In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients
- A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:
- Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.
- Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis
- Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects
- Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor
- Ticagrelor in Severe Community Acquired Pneumonia
- Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome
- Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI
- OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial
- Ticagrelor for PCI Post Thrombolysis
- Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion
- High Ticagrelor Loading Dose in STEMI
- Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor
- Brilinta DaYu Study
- Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study
- Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
- Effect of Ticagrelor on Endothelial Function
- Cangrelor Ticagrelor Transition Study
- Tailored Antiplatelet Therapy Following PCI
- Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention
- Impact of Ticagrelor Re-load on Pharmacodynamic Profiles
- Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel
- Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
- Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery
Clinical trials list
click for details